Methylene Blue for Cognitive Dysfunction in Bipolar Disorder

Clinical trial NCT00214877 · COMPLETED

Trial details

NCT number: NCT00214877
Sponsor: Nova Scotia Health Authority
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2003-11-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.